58 related articles for article (PubMed ID: 6277480)
1. Natural and antibody-dependent cell-mediate cytotoxicity to cultured target cells superinfected with Epstein-Barr virus.
Takasugi M; Mickey MR; Levine PH
Cancer Res; 1982 Apr; 42(4):1208-14. PubMed ID: 6277480
[TBL] [Abstract][Full Text] [Related]
2. Apparent sensitivity of human K lymphocytes to the spatial orientation and organization of target cell-bound antibodies as measured by the efficiency of antibody-dependent cellular cytotoxicity (ADCC).
Christiaansen JE; Burnside SS; Sears DW
J Immunol; 1987 Apr; 138(7):2236-43. PubMed ID: 3549899
[TBL] [Abstract][Full Text] [Related]
3. Identification of target antigen for antibody-dependent cellular cytotoxicity on cells carrying Epstein-Barr virus genome.
Takaki K; Harada M; Sairenji T; Hinuma Y
J Immunol; 1980 Nov; 125(5):2112-7. PubMed ID: 6253564
[TBL] [Abstract][Full Text] [Related]
4. The Epstein-Barr virus-encoded glycoprotein gp 110 (BALF 4) can serve as a target for antibody-dependent cell-mediated cytotoxicity (ADCC).
Jilg W; Bogedain C; Mairhofer H; Gu SY; Wolf H
Virology; 1994 Aug; 202(2):974-7. PubMed ID: 8030258
[TBL] [Abstract][Full Text] [Related]
5. Immunotherapy and enhanced antibody-dependent cell-mediated cytotoxicity using virally-infected target cells.
Bosse D; Ades EW
J Clin Lab Immunol; 1989 Jul; 29(3):109-10. PubMed ID: 2561291
[TBL] [Abstract][Full Text] [Related]
6. Antibody-dependent cellular cytotoxicity (ADCC) against Epstein-Barr virus-determined antigens II. Induction of ADCC by FC-FC receptor bridging.
Jondal M
Clin Exp Immunol; 1977 Jul; 29(1):1-10. PubMed ID: 196801
[TBL] [Abstract][Full Text] [Related]
7. [Cytotoxicity induced by the serum of patients with AIDS and at high risk of AIDS against cells infected with Epstein-Barr virus].
De la Barrera S; Fejes M; Riera NE; Scaglione C; Pérez Blanco R; de Bracco MM
Rev Argent Microbiol; 1985; 17(3):137-43. PubMed ID: 2829276
[TBL] [Abstract][Full Text] [Related]
8. Role of antibodies in the specificity of natural cell-mediated cytotoxicity.
Takasugi M; Akira D
J Natl Cancer Inst; 1979 Jun; 62(6):1361-5. PubMed ID: 286107
[TBL] [Abstract][Full Text] [Related]
9. Reconstitution of natural cell-mediated cytotoxicity with specific antibodies.
Takasugi J; Koide Y; Takasugi M
Eur J Immunol; 1977 Dec; 7(12):887-92. PubMed ID: 75804
[TBL] [Abstract][Full Text] [Related]
10. Virus-induced enhancement of lymphocyte-mediated antibody-dependent cytotoxicity (ADCC) in vitro.
Alsheikhly AR; Wåhlin B; Andersson T; Perlmann P
J Immunol; 1984 Jun; 132(6):2760-6. PubMed ID: 6373918
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the natural cell mediated and antibody dependent cell mediated cytotoxicity measured as a function of target cell number in patients with mammary tumors and healthy female blood donors.
Bakaćs T; Garam T; Ringwald G; Tótpál K; Svastits E
Arch Geschwulstforsch; 1981; 51(4):327-37. PubMed ID: 7316684
[TBL] [Abstract][Full Text] [Related]
12. Murine antibody-dependent cellular cytotoxicity to herpes simplex virus-infected target cells.
Kohl S; Cahall DL; Walters DL; Schaffner VE
J Immunol; 1979 Jul; 123(1):25-30. PubMed ID: 448149
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus (EBV)--lymphoid cell interactions. II. The influence of the EBV replication cycle on natural killing and antibody-dependent cellular cytotoxicity against EBV-infected cells.
Patel PC; Menezes J
Clin Exp Immunol; 1982 Jun; 48(3):589-601. PubMed ID: 6288292
[TBL] [Abstract][Full Text] [Related]
14. Human colostral cytotoxicity: I. Antibody-dependent cellular cytotoxicity against Herpes simplex viral-infected cells mediated by colostral cells.
Kohl S; Malloy MM; Pickering LK; Morriss FH; Adcock EW; Walters DL
J Clin Lab Immunol; 1978 Nov; 1(3):221-4. PubMed ID: 756470
[TBL] [Abstract][Full Text] [Related]
15. Unusually efficient tumor cell lysis by human effectors of antibody-dependent cellular cytotoxicity mediated by monoclonal antibodies.
Christiaansen JE; Sears DW
Cancer Res; 1984 Sep; 44(9):3712-8. PubMed ID: 6744288
[TBL] [Abstract][Full Text] [Related]
16. A prospective study: evaluation of the antibody-dependent cell-mediated cytotoxicity assay in chronic active Epstein-Barr syndrome.
Waters-Peacocke N; Wray BB; Ades EW
J Clin Lab Immunol; 1988 Sep; 27(1):11-2. PubMed ID: 2855078
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of human antibody-dependent cellular cytotoxicity, cell-mediated cytotoxicity, and natural killing by a xenogeneic antiserum prepared against "activated" alloimmune human lymphocytes.
Neville ME; Hiserodt JC
J Immunol; 1982 Mar; 128(3):1246-51. PubMed ID: 6976989
[TBL] [Abstract][Full Text] [Related]
18. [The reaction of antibody-dependent cell-mediated cytotoxicity (ADCC)].
Hanton G; Pastoret PP
Ann Rech Vet; 1984; 15(4):443-54. PubMed ID: 6529114
[TBL] [Abstract][Full Text] [Related]
19. Human polymorphonuclear leucocytes as mediators of antibody-dependent cellular cytotoxicity to herpes simplex virus-infected cells.
Oleske JM; Ashman RB; Kohl S; Shore SL; Starr SE; Wood P; Nahmias AJ
Clin Exp Immunol; 1977 Mar; 27(3):446-53. PubMed ID: 193661
[TBL] [Abstract][Full Text] [Related]
20. Restricted effector cell function in ADCC.
McConnachie PR; Lower F; McIntyre JA
Diagn Immunol; 1985; 3(2):67-74. PubMed ID: 4042534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
